Tag : Canagliflozin

Latest News

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c <7%: Results From the CREDENCE Trial

Newsemia
Cannon, CP; Perkovic, V; Agarwal, R; Baldassarre, J; Bakris, G; Charytan, DM; de Zeeuw, D; … Mahaffey, KW; + view all Cannon, CP; Perkovic, V;...
Latest News

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results From the Randomized CREDENCE Trial

Newsemia
Mahaffey, KW; Jardine, M; Bompoint, S; Cannon, C; Bruce, N; Herspink, LHJ; Charytan, D; … Perkovic, V; + view all Mahaffey, KW; Jardine, M; Bompoint,...
Neurology

CANVAS: Reassuring Data on Stroke With Canagliflozin

Newsemia
More detailed data from the CANVAS program have been reported showing reassuring results on all stroke types and a significant reduction in hemorrhagic stroke. Medscape...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy